Safety and tolerability of oseltamivir in patients with multiple sclerosis: a pilot study

被引：0
|
作者：
Tselis, Alex [1 ]
Harrison, Vincent [1 ]
Mckenzie, Megan [1 ]
Khan, Omar [1 ]
机构：
[1] Wayne State Univ, Detroit, MI USA
来源：
MULTIPLE SCLEROSIS | 2008年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S182 / S182
页数：1
相关论文
共 50 条
  • [21] A pilot study of the tolerability, safety and efficacy of CPHPC in patients with systemic amyloidosis
    Gillmore, J. D.
    Offer, M.
    Lachmann, H. J.
    Goodman, H. J.
    Tennent, G. A.
    Gallimore, J. R.
    Pepys, M. B.
    Hawkins, P. N.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2006, 13 : 30 - 31
  • [22] Corneal Parameters in Patients with Multiple Sclerosis: A Pilot Study
    Kilic, Soner
    Gundogan, Medine
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2022, 239 (12) : 1489 - 1492
  • [23] Cerebellar volumetry in patients with multiple sclerosis - a pilot study
    Weier, K.
    Amann, M.
    Beck, A.
    Penner, I. K.
    Radue, E. W.
    Stippich, C.
    Kappos, L.
    Sprenger, T.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S370 - S371
  • [24] Quality of life in patients with multiple sclerosis: a pilot study
    De Pascale, I.
    JOURNAL OF PSYCHOPATHOLOGY-GIORNALE DI PSICOPATOLOGIA, 2013, 19 (02): : 126 - 133
  • [25] Immunoadsorption in patients with multiple sclerosis: A pilot study.
    Moldenhauer, A
    Kiesewetter, H
    Kalus, U
    von Volkmann, B
    Waescher, C
    Derfuss, T
    Haas, J
    Salama, A
    BLOOD, 2003, 102 (11) : 135B - 135B
  • [26] Efficacy, safety and tolerability of natalizumab in Turkish multiple sclerosis patients with high disease activity: a prospective, multicentre study
    Eraksoy, M.
    Akman-Demir, G.
    Agan, K.
    Gunal, D.
    Us, O.
    Saip, S.
    Demirci, N. O.
    Tutuncu, M.
    Turan, O. F.
    Taskapilioglu, O.
    Boz, C.
    Terzi, M.
    Onar, M.
    Aydin-Gungor, H.
    Turk-Boru, U.
    Soysal, A.
    Petek-Balci, B.
    Turkoglu, R.
    Dib, H.
    Siva, A.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S209 - S209
  • [27] Safety, efficacy, and tolerability of alemtuzumab in pediatric patients with active relapsing-remitting multiple sclerosis: The LemKids study
    Chitnis, Tanuja
    Arnold, Douglas L.
    Quartier, Pierre
    Chirieac, Magdalena
    Hu, Wenruo
    Jurgensen, Stephanie
    Havrdova, Eva K.
    MULTIPLE SCLEROSIS JOURNAL, 2025, 31 (01) : 23 - 35
  • [28] Maintenance of efficacy, safety and tolerability of ponesimod in patients with relapsing remitting multiple sclerosis: phase II extension study
    Pozzilli, C.
    Fernandez, O.
    Olsson, T.
    Freedman, M. S.
    Melanson, M.
    Boster, A.
    Radue, E-W
    Hennessy, B.
    Rames, A.
    D'Ambrosio, D.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 456 - 457
  • [29] Ongoing evaluation of the safety and tolerability of Novantrone® (mitoxantrone) worsening multiple sclerosis:: the RENEW study
    Fox, E.
    Al-Sabbagh, A.
    Bennett, R.
    Coyle, P.
    Mikol, D.
    Panitch, H.
    Rivera, V.
    Rolak, L.
    Sheremata, W.
    Elias, S. B.
    MULTIPLE SCLEROSIS, 2006, 12 : S217 - S217
  • [30] Long-term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing study
    Paolicelli, Damiano
    Manni, Alessia
    Direnzo, Vita
    D'Onghia, Mariangela
    Tortorella, Carla
    Zoccolella, Stefano
    Trojano, Maria
    JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55 (10): : 1131 - 1136
12345